Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Number of Aurobindo Pharma Limited's ANDAs in India by therapy FY 2018
Number of abbreviated new drug applications (ANDAs) of Aurobindo Pharma Limited in India in FY 2018, by therapy
This statistic shows the number of the abbreviated new drug applications (ANDAs) by Aurobindo Pharma Limited in financial year 2018 as per various therapies. As seen in the graph, the central nervous system (CNS) therapy drugs made up for 90 of the new drug applications by Aurobindo Pharma.
Number of abbreviated new drug applications (ANDAs) of Aurobindo Pharma Limited in India in FY 2018, by therapy
| Number of ANDAs | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Number of ANDAs | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- April 2018
- Region
- India
- Survey time period
- FY 2018
- Supplementary notes
-
*As per IQVIA MAT March 2018.
ANDA: Abbreviated New Drug Application.
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.
Source
- Show sources information
- Show publisher information
- Release date
- April 2018
More information
- Region
- India
- Survey time period
- FY 2018
- Supplementary notes
-
*As per IQVIA MAT March 2018.
ANDA: Abbreviated New Drug Application.
India's fiscal year starts in April and ends in March. For example, FY 2018 started in April 2017 and ended in March 2018.
Other statistics on the topic
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
- Key figures
- Size of the healthcare market in India from 2012 to 2020 (in billion U.S. dollars)Size of the healthcare sector in India 2012-2020
- Value of public health expenditure in India from FY 2014 to FY 2018 (in trillion Indian rupees)*Value of public health expenditure in India 2013-2018
- Share of pharmaceutical market revenue in India in 2018, by sub segmentDistribution of pharmaceutical market revenue in India by sub segment 2018
- Net sales of Indian pharma companies from H1 2017 to H1 2019 (in billion Indian rupees)Net sales of Indian pharma companies in 2017-2019
- Net profit margin of Indian pharma companies from H1 2017 to H1 2019Net profit margin of Indian pharma industry in 2017-2019
- R&D investments as a share of sales by Indian pharma companies from H1 2017 to H1 2019Share of R&D investments by Indian pharma companies in 2017-2019
- Rate of approval for Indian ANDAs by the U.S. FDA from H1 2017 to H1 2019Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Finances and trade
- Value of India's medicine and pharmaceutical product imports from FY 2011 to FY 2019 (in billion Indian rupees)India's medicine and pharmaceutical product imports by value 2000-2019
- Main destinations for Indian drugs and pharmaceutical exports in FY 2018, based on value (in billion Indian rupees)Indian drugs and pharmaceutical exports by target country 2018
- Amount of foreign direct investment (FDI) equity inflows for the drugs and pharmaceuticals sector in India from FY 2015 to FY 2019 (in million U.S. dollars)FDI equity inflow amount for drugs and pharmaceuticals sector in India 2014-2019
- Value of mergers and acquisitions of Indian companies in the pharmaceuticals sector from 2014 to 2017 (in billion U.S. dollars)M&A value in the pharmaceuticals sector across India 2014-2017
- Revenue generated in analytics market by pharma and healthcare sector across India in 2016 and 2017 (in million US dollars)Revenue in analytics market by pharma and healthcare sector India 2016-2017
- Number of Indian ANDAs approved by the U.S. FDA from H1 2017 to H1 2019Number of Indian ANDA approvals by the U.S. FDA 2017-2019
- Key players
- Leading pharmaceutical companies in India as of 2019, by net profits (in billion Indian rupees)Top pharma companies India 2019 by net profit
- Global revenue of Cipla Limited in India in FY 2018, by region (in billion Indian rupees)Global revenue of Cipla Limited in India by region 2018
- Total income for GSK Pharmaceuticals Limited in India in FY 2017 and FY 2019 (in billion Indian rupees)Total income for GSK Pharmaceuticals Limited in India 2016-2019
- Revenue from global generic drugs from Dr. Reddy's Laboratories Limited in FY 2019, by region (in billion Indian rupees)Revenue from global generics from Dr. Reddy's Laboratories by region 2019
- Profits after tax Sun pharma in India in FY 2017 and FY 2018 (in billion Indian rupees)Sun pharma India profits after tax 2016-2018
- Revenue of Aurobindo Pharma Limited from FY 2013 to FY 2019 (in billion Indian rupees)Revenue of Aurobindo Pharma Limited in India 2012-2019
- Future outlook
- Value of retail pharmaceutical market in India from FY 2017 to FY 2023 (in billion U.S. dollars)Market size of retail pharma India 2016-2023
- Value of the nutraceutical market across India in 2012 and 2017 with a forecast for 2022 (in billion Indian rupees)Value of the nutraceutical market in India 2012-2022
- Projected size of India's mHealth devices and services market from 2014 to 2020 (in million U.S. dollars)Indian mHealth market size by device and service 2014-2020
- Share of online pharmacies in India from 2019 to 2023, by market type Share of online pharmacies India 2019-2023 by market type
- Market size therapy drugs Aurobindo Pharma Limited in India by type FY 2018
- Net debt to EBITDA ratio of Aurobindo Pharma Limited in India 2012-2018
- EBITDA of Aurobindo Pharma Limited in India 2012-2018
- Share of EBITDA margin of Aurobindo Pharma Limited in India 2012-2018
- Net debt to equity ratio of Aurobindo Pharma Limited in India 2012-2018
- Net profits of Aurobindo Pharma Limited in India 2012-2018
- Revenue of Aurobindo Pharma Limited in India 2012-2019
- Share of revenue of Aurobindo Pharma Limited in India FY 2018, by type
- Revenue from EU formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from ARV formulations of Aurobindo Pharma Limited 2012-2018
- Revenue from ARV formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from EU formulations of Aurobindo Pharma Limited 2012-2018
- Share of revenue from growth market formulations of Aurobindo Pharma 2012-2018
- Share of revenue from U.S. formulations of Aurobindo Pharma Limited 2012-2018
- Expenditure on R&D by Aurobindo Pharma Limited 2016-2018 by type
- Revenue from U.S. formulations of Aurobindo Pharma Limited 2012-2018
- Revenue from growth market formulations of Aurobindo Pharma Limited 2012-2018
- Daiichi Sankyo's total assets FY 2012-2017
- Gross profit of Dr. Reddy's Laboratories Limited in India FY 2014-2018
- Pharmaceutical industry in India
- Lundbeck Annual Report 2018
- Novo Nordisk ANNUAL REPORT 2017
- LEO Pharma A/S Annual Report 2017
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology Industry in Europe
- Lundbeck Annual Report 2017
- Teva - 2018 Form 10-K
- Boehringer Ingelheim - Annual Report 2018
- Medtronic - 2019 Form 10-K
- Value and Innovation Framework Report 2019
- Pharmaceutical industry in the Netherlands
- Indicatori Farmaceutici
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
...and make my research life easier.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.